NITYR is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Cycle Pharmaceuticals Ltd.. The primary component is Nitisinone.
Product ID | 70709-002_287a3a70-3548-4cb8-bf81-1c333aac91b1 |
NDC | 70709-002 |
Product Type | Human Prescription Drug |
Proprietary Name | NITYR |
Generic Name | Nitisinone |
Dosage Form | Tablet |
Route of Administration | ORAL |
Marketing Start Date | 2017-07-26 |
Marketing Category | NDA / NDA |
Application Number | NDA209449 |
Labeler Name | Cycle Pharmaceuticals Ltd. |
Substance Name | NITISINONE |
Active Ingredient Strength | 2 mg/1 |
Pharm Classes | 4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC],Hydroxyphenylpyruvate Dioxygenase Inhibitors [MoA],Cytochrome P450 2C9 Inhibitors [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 2017-07-26 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA209449 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2017-07-26 |
Ingredient | Strength |
---|---|
NITISINONE | 2 mg/1 |
SPL SET ID: | 00fd1905-27e4-420e-8dc5-a69e4ddc1526 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
70709-000 | NITYR | Nitisinone |
70709-002 | NITYR | Nitisinone |
70709-005 | NITYR | Nitisinone |
0254-3020 | Nitisinone | Nitisinone |
0254-3021 | Nitisinone | Nitisinone |
0254-3022 | Nitisinone | Nitisinone |
63629-2233 | Nitisinone | Nitisinone |
63629-2234 | Nitisinone | Nitisinone |
63629-2235 | Nitisinone | Nitisinone |
70505-202 | Nitisinone | Nitisinone |
70505-205 | Nitisinone | Nitisinone |
70505-210 | Nitisinone | Nitisinone |
66658-102 | Orfadin | Nitisinone |
66658-105 | Orfadin | Nitisinone |
66658-110 | Orfadin | Nitisinone |
66658-120 | Orfadin | Nitisinone |
66658-204 | ORFADIN | nitisinone |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
NITYR 87604011 5716643 Live/Registered |
Cycle Pharmaceuticals Ltd. 2017-09-11 |